• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    AiViva Completes Enrollment In Phase 1 Trial Of AIV007 For AMD And DME

    26 Aug 2024 //

    PHARMABIZ

    AiViva Completes Phase 1 Trial Enrollment For AMD And DME Treatment

    23 Aug 2024 //

    GLOBENEWSWIRE

    AiViva Biopharma Completes Phase 1/2 Clinical Trial of AIV001

    11 Dec 2023 //

    GLOBENEWSWIRE

    AiViva Biopharma Appoints Lester J. Kaplan, PhD to the Board of Directors

    18 Sep 2023 //

    GLOBENEWSWIRE

    AiViva Biopharma Appoints Jung-Chin (Rongjin) Lin, to the Board of Directors

    29 Aug 2023 //

    GLOBENEWSWIRE

    AiViva Biopharma Initiates Phase 1 Clinical Trial of AIV007

    22 May 2023 //

    GLOBENEWSWIRE

    AiViva Biopharma Initiates Phase 1/2 Clinical Trial of AIV001 for Nonmelanoma

    03 Oct 2020 //

    GLOBENEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.